Cancer Immunology and Immunotherapy: Taking a Place in Mainstream Oncology

癌症免疫学和免疫治疗：在主流肿瘤学中占有一席之地

• 批准号: 9328546
• 负责人: Jane Peterson
• 金额: $ 0.7万
• 依托单位: KEYSTONE SYMPOSIA
• 依托单位国家: 美国
• 财政年份: 2017
• 资助国家: 美国
• 起止时间: 2017-03-09 至 2018-02-28
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9328546
• 关键词: Advanced Development; Antibody Therapy; Area; British Columbia; Canada; Cancer Immunology Science; Cancer Patient; Cancer Vaccines; Cell Therapy; Clinical; Collaborations; Complex; Data; Development; Engineering; Genetic; Goals; Government; Growth; Immune; Immune system; Immunity; Immunologist; Immunology; Immunotherapy; Industrialization; Knowledge; Mainstreaming; Malignant Neoplasms; Mentors; Metabolism; Methodology; Monitor; Mono-S; Neoplasm Metastasis; Outcome; Pathway interactions; Research; Research Personnel; Role; Science; Scientist; Technology; Tumor Biology; Vaccines; base; cancer immunotherapy; cancer therapy; cellular engineering; clinical practice; combinatorial; design; immunoregulation; insight; neoplasm immunotherapy; neoplastic cell; next generation; novel strategies; oncology; planetary Atmosphere; posters; prospective; symposium; treatment response; tumor; tumor microenvironment

ABSTRACT Support is requested for a Keystone Symposia conference entitled Cancer Immunology and Immunotherapy: Taking a Place in Mainstream Oncology, organized by Drs. Robert D. Schreiber, James P. Allison, Philip D. Greenberg and Glenn Dranoff. The conference will be held in Whistler, British Columbia, Canada from March 19-23, 2017. The fields of cancer immunology and immunotherapy continue to make great strides in providing both a comprehensive understanding of the basic mechanisms underlying tumor-immune system interactions and applying this knowledge to the development of effective immune-based cancer therapies. As such, this conference is organized to highlight recent insights into the complex roles of immune components and pathways in controlling or alternatively promoting cancer and to showcase recent uses of cancer vaccines, checkpoint blocking strategies, adoptive cell therapies and cellular engineering approaches, either as mono- or combinatorial therapies, that have resulted in durable, effective and safe therapeutic responses to an increasing number of cancer patients. Part of the conference will also focus on new, developing technologies that are likely to expand our capacity to monitor the effects of cancer immunotherapy with a precision, refinement and at a level that has not been possible in the past. Both established and up-and-coming investigators will have ample opportunities to interact informally and share views with junior investigators and trainees in a collegial and relaxed atmosphere.

抽象的 请求支持题为“癌症免疫学和免疫治疗”的 Keystone 研讨会： 在主流肿瘤学中占据一席之地，由 Drs 组织。罗伯特·D·施赖伯、詹姆斯·P·艾利森、菲利普·D· 格林伯格和格伦·德拉诺夫。会议将于3月起在加拿大不列颠哥伦比亚省惠斯勒举行 2017年19-23日，癌症免疫学和免疫治疗领域继续取得长足进步，为患者提供 全面了解肿瘤与免疫系统相互作用的基本机制 并将这些知识应用于开发有效的基于免疫的癌症疗法。因此，这 组织会议的目的是强调对免疫成分和免疫成分的复杂作用的最新见解 控制或促进癌症的途径并展示癌症疫苗的最新用途， 检查点阻断策略、过继细胞疗法和细胞工程方法，无论是单一还是 联合疗法，对一种疾病产生了持久、有效和安全的治疗反应 癌症患者数量不断增加。会议的一部分还将重点关注新兴技术 这可能会扩大我们精确监测癌症免疫疗法效果的能力， 精细程度达到了过去不可能的水平。无论是成熟的还是崭露头角的 调查人员将有充足的机会与初级调查人员进行非正式互动并分享观点 学员们在融洽、轻松的氛围中进行交流。